|
LOC144438 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53279619499835E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0529999922303E-09 |
| Normal-vs-Stage2 |
3.397000E-04 |
| Normal-vs-Stage3 |
6.89359680450252E-11 |
| Normal-vs-Stage4 |
4.53210025064266E-10 |
| Stage1-vs-Stage2 |
4.651000E-01 |
| Stage1-vs-Stage3 |
6.374300E-02 |
| Stage1-vs-Stage4 |
3.866400E-02 |
| Stage2-vs-Stage3 |
6.386400E-02 |
| Stage2-vs-Stage4 |
3.639500E-02 |
| Stage3-vs-Stage4 |
5.351000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08760001005237E-10 |
| Normal-vs-AfricanAmerican |
1.178880E-03 |
| Normal-vs-Asian |
2.95400000016599E-07 |
| Caucasian-vs-AfricanAmerican |
4.187200E-01 |
| Caucasian-vs-Asian |
9.818000E-01 |
| AfricanAmerican-vs-Asian |
4.148600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37529998500696E-09 |
| Normal-vs-Female |
1.63010049902823E-10 |
| Male-vs-Female |
6.455600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58019999810344E-08 |
| Normal-vs-Age(41-60Yrs) |
3.3957999745482E-09 |
| Normal-vs-Age(61-80Yrs) |
3.36199956763039E-10 |
| Normal-vs-Age(81-100Yrs) |
3.076400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.547600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.531830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.692200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.594800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.128800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.697000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.36480000000472E-05 |
| Classical-VS-Follicular |
1.101830E-01 |
| Classical-VS-Other |
5.673400E-01 |
| Classical-VS-Normal |
8.53769999142884E-09 |
| Tall-VS-Follicular |
2.211700E-02 |
| Tall-VS-Other |
2.006200E-01 |
| Tall-VS-Normal |
3.651201563315E-11 |
| Follicular-VS-Other |
9.851200E-01 |
| Follicular-VS-Normal |
9.91509999659357E-08 |
| Other-VS-Normal |
1.149640E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75930003898372E-09 |
| Normal-vs-N1 |
2.76139999755287E-10 |
| N0-vs-N1 |
8.572100E-02 |
|
|
